HEADER PROTEIN TRANSPORT 21-JUL-04 1U3B TITLE AUTO-INHIBITION MECHANISM OF X11S/MINTS FAMILY SCAFFOLD PROTEINS TITLE 2 REVEALED BY THE CLOSED CONFORMATION OF THE TANDEM PDZ DOMAINS COMPND MOL_ID: 1; COMPND 2 MOLECULE: AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER COMPND 3 1; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: PDZ12C DOMAIN; COMPND 6 SYNONYM: X11ALPHA/MINT1, PHOSPHOTYROSINE-BINDING/-INTERACTING DOMAIN COMPND 7 (PTB)-BEARING PROTEIN, NEURONAL MUNC18-1-INTERACTING PROTEIN 1, COMPND 8 NEURON-SPECIFIC X11 PROTEIN, ADAPTOR PROTEIN X11ALPHA; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET32A KEYWDS X11S/MINTS, PDZ DOMAIN, SCAFFOLD PROTEIN, PROTEIN TRAFFICKING, KEYWDS 2 PROTEIN TRANSPORT EXPDTA SOLUTION NMR MDLTYP MINIMIZED AVERAGE AUTHOR W.FENG,J.-F.LONG,L.-N.CHAN,C.HE,A.FU,J.XIA,N.Y.IP,M.ZHANG REVDAT 4 02-MAR-22 1U3B 1 REMARK SEQADV REVDAT 3 24-FEB-09 1U3B 1 VERSN REVDAT 2 13-SEP-05 1U3B 1 JRNL REVDAT 1 26-JUL-05 1U3B 0 JRNL AUTH J.-F.LONG,W.FENG,R.WANG,L.-N.CHAN,F.C.IP,J.XIA,N.Y.IP, JRNL AUTH 2 M.ZHANG JRNL TITL AUTOINHIBITION OF X11/MINT SCAFFOLD PROTEINS REVEALED BY THE JRNL TITL 2 CLOSED CONFORMATION OF THE PDZ TANDEM JRNL REF NAT.STRUCT.MOL.BIOL. V. 12 722 2005 JRNL REFN ISSN 1545-9993 JRNL PMID 16007100 JRNL DOI 10.1038/NSMB958 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1, CNS 1.1 REMARK 3 AUTHORS : BRUNGER, A.T. (CNS), BRUNGER, A.T. (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1U3B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 26-JUL-04. REMARK 100 THE DEPOSITION ID IS D_1000023191. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: FIRSTLY, SELECT 20 STRUCTURES FROM CALCULATED 200 REMARK 210 STRUCTURES WITH THE CRITERIA OF LOWEST ENERGY; SECONDLY, REMARK 210 CALCULATE THE MINIMIZED AVERAGE STRUCTURE USING THE SELECTED 20 REMARK 210 STRUCTURES; THIRDLY, SUBMIT THIS AVERAGE STRUCTURE AS THE REMARK 210 STRUCTURAL MODEL OF PDZ12C REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 30 -78.87 17.12 REMARK 500 LEU A 31 -43.51 -179.79 REMARK 500 SER A 38 85.64 -68.38 REMARK 500 TRP A 40 -159.68 -61.78 REMARK 500 SER A 42 42.24 79.95 REMARK 500 PRO A 45 90.17 -53.06 REMARK 500 THR A 46 -154.58 -139.59 REMARK 500 PRO A 82 -179.07 -68.93 REMARK 500 ASN A 95 61.44 -102.78 REMARK 500 ASN A 129 -69.79 66.64 REMARK 500 ILE A 153 -84.55 -132.93 REMARK 500 ALA A 175 52.10 -109.69 REMARK 500 ARG A 190 60.93 -104.21 REMARK 500 LEU A 191 -90.57 29.24 REMARK 500 LEU A 192 -45.25 -134.74 REMARK 500 ALA A 194 80.53 69.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1U37 RELATED DB: PDB REMARK 900 THE SAME PROTEIN, PDZ1 DOMAIN, 20 STRUCTURES REMARK 900 RELATED ID: 1U38 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEX WITH C-PEPTIDE, 20 STRUCTURES REMARK 900 RELATED ID: 1U39 RELATED DB: PDB REMARK 900 THE SAME PROTEIN, PDZ2 DOMAIN, 20 STRUCTURES DBREF 1U3B A 19 201 UNP Q02410 APBA1_HUMAN 655 837 SEQADV 1U3B GLU A 17 UNP Q02410 CLONING ARTIFACT SEQADV 1U3B PHE A 18 UNP Q02410 CLONING ARTIFACT SEQRES 1 A 185 GLU PHE LYS ASP VAL PHE ILE GLU LYS GLN LYS GLY GLU SEQRES 2 A 185 ILE LEU GLY VAL VAL ILE VAL GLU SER GLY TRP GLY SER SEQRES 3 A 185 ILE LEU PRO THR VAL ILE ILE ALA ASN MET MET HIS GLY SEQRES 4 A 185 GLY PRO ALA GLU LYS SER GLY LYS LEU ASN ILE GLY ASP SEQRES 5 A 185 GLN ILE MET SER ILE ASN GLY THR SER LEU VAL GLY LEU SEQRES 6 A 185 PRO LEU SER THR CYS GLN SER ILE ILE LYS GLY LEU LYS SEQRES 7 A 185 ASN GLN SER ARG VAL LYS LEU ASN ILE VAL ARG CYS PRO SEQRES 8 A 185 PRO VAL THR THR VAL LEU ILE ARG ARG PRO ASP LEU ARG SEQRES 9 A 185 TYR GLN LEU GLY PHE SER VAL GLN ASN GLY ILE ILE CYS SEQRES 10 A 185 SER LEU MET ARG GLY GLY ILE ALA GLU ARG GLY GLY VAL SEQRES 11 A 185 ARG VAL GLY HIS ARG ILE ILE GLU ILE ASN GLY GLN SER SEQRES 12 A 185 VAL VAL ALA THR PRO HIS GLU LYS ILE VAL HIS ILE LEU SEQRES 13 A 185 SER ASN ALA VAL GLY GLU ILE HIS MET LYS THR MET PRO SEQRES 14 A 185 ALA ALA MET TYR ARG LEU LEU THR ALA GLN GLU GLN PRO SEQRES 15 A 185 VAL TYR ILE HELIX 1 1 GLY A 56 GLY A 62 1 7 HELIX 2 2 PRO A 82 LEU A 93 1 12 HELIX 3 3 GLY A 139 GLY A 145 1 7 HELIX 4 4 PRO A 164 ASN A 174 1 11 SHEET 1 A 5 PHE A 18 GLU A 24 0 SHEET 2 A 5 ARG A 98 VAL A 104 -1 O LEU A 101 N VAL A 21 SHEET 3 A 5 GLN A 69 ILE A 73 -1 N GLN A 69 O VAL A 104 SHEET 4 A 5 VAL A 47 MET A 52 -1 N VAL A 47 O ILE A 70 SHEET 5 A 5 VAL A 33 GLU A 37 -1 N VAL A 34 O ASN A 51 SHEET 1 B 4 PHE A 18 GLU A 24 0 SHEET 2 B 4 ARG A 98 VAL A 104 -1 O LEU A 101 N VAL A 21 SHEET 3 B 4 GLN A 69 ILE A 73 -1 N GLN A 69 O VAL A 104 SHEET 4 B 4 THR A 76 SER A 77 -1 O THR A 76 N ILE A 73 SHEET 1 C 4 THR A 110 ARG A 116 0 SHEET 2 C 4 GLY A 177 PRO A 185 -1 O ILE A 179 N ILE A 114 SHEET 3 C 4 HIS A 150 ILE A 155 -1 N ARG A 151 O MET A 184 SHEET 4 C 4 GLN A 158 SER A 159 -1 O GLN A 158 N ILE A 155 SHEET 1 D 2 PHE A 125 GLN A 128 0 SHEET 2 D 2 ILE A 131 LEU A 135 -1 O ILE A 131 N GLN A 128 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000